ELQ-300 - HY-13836
Nur noch %1 verfügbar
Catalog #
HY-13836
Ab
124,00 €
ELQ-300 is a potent and orally bioavailable antimalarial agent, acts as an inhibitor of the reductive (Qi) site of the cytochrome bc1 complex (cyt bc1). ELQ-300 inhibits growth of P. falciparum Dd2, Tm90-C2B, and D1 with IC50 values of 6.6, 4.6 and 160 nM, respectively. ELQ-300 can be used for the research of antimalarial[1][2].
| Datasheet URL | http://file.medchemexpress.com/batch_PDF/HY-13836/ELQ-300-DataSheet-MedChemExpress.pdf |
|---|---|
| Shipping | Room Temperature |
| Application | COVID-19-immunoregulation |
| CAS | 1354745-52-0 |
| Storage | -20°C, 3 years; 4°C, 2 years (Powder) |
| MWT | 475.84 |
| Solubility | DMSO : 15.62 mg/mL (ultrasonic) |
| Clinical Information | No Development Reported |
| Target | Parasite |
| Application: | COVID-19-immunoregulation |
|---|